These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2130003)

  • 1. Correlation between disc potency and zone size in temafloxacin activity in vitro.
    Reggio S; Bassanetti I; Ceralli M; Giardini R; Sansonetti G
    Drugs Exp Clin Res; 1990; 16(12):611-4. PubMed ID: 2130003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation into the antibacterial activity in vitro of cement-antibiotic mixtures.
    Greco F; Rossi A; De Palma L; Spagnolo N
    Ital J Orthop Traumatol; 1981 Apr; 7(1):103-13. PubMed ID: 6799427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of fluoroquinolone administration on the emergence of fluoroquinolone-resistant gram-negative bacilli from gastrointestinal flora.
    Richard P; Delangle MH; Raffi F; Espaze E; Richet H
    Clin Infect Dis; 2001 Jan; 32(1):162-6. PubMed ID: 11112677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000.
    Zervos MJ; Hershberger E; Nicolau DP; Ritchie DJ; Blackner LK; Coyle EA; Donnelly AJ; Eckel SF; Eng RH; Hiltz A; Kuyumjian AG; Krebs W; McDaniel A; Hogan P; Lubowski TJ
    Clin Infect Dis; 2003 Dec; 37(12):1643-8. PubMed ID: 14689346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro anti-microbial susceptibility of clinical isolates of pathogenic bacteria to ten antibiotics including phosphomycin.
    Eke PI; Rotimi VO
    Afr J Med Med Sci; 1987 Mar; 16(1):1-8. PubMed ID: 3037870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Phenotypes of resistance to antibiotics of the most frequently isolated strains in five specialized hospital centers. Multicenter study].
    Gabastou JM; Chouaki T; Mangeot J; Zemir A; Manuel C; Lepitre M; Gravisse J; Cornel E; Denis-Jacquot N; Mahuzier G
    Pathol Biol (Paris); 1995 Apr; 43(4):320-3. PubMed ID: 7567123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on pyridonecarboxylic acids as antibacterial agents. VI. Synthesis and antibacterial activity of 7-chloro-6-fluoro-1-ethyt-1, 4-dihydro-4-oxopyrido(2,3-c)pyridazine-3-carboxylic acid and derivatives].
    Guo HY; Sun LY; Tang Y; Yan GH; Zhang ZP
    Yao Xue Xue Bao; 1988; 23(8):566-73. PubMed ID: 3151035
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibacterial activities of Emblica officinalis and Coriandrum sativum against Gram negative urinary pathogens.
    Saeed S; Tariq P
    Pak J Pharm Sci; 2007 Jan; 20(1):32-5. PubMed ID: 17337425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Increased antibacterial activity of antibiotics with etonium in vitro].
    Petrunyk IO
    Mikrobiol Z; 2000; 62(4):43-6. PubMed ID: 11421003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antimicrobial spectrum of Xeroform
    Barillo DJ; Barillo AR; Korn S; Lam K; Attar PS
    Burns; 2017 Sep; 43(6):1189-1194. PubMed ID: 28641915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gentamicin susceptibility of gram-negative problem germs and staphylococci, indicated by the tube dilution method].
    Modde H
    Pathol Microbiol (Basel); 1972; 38(4):286-95. PubMed ID: 4565703
    [No Abstract]   [Full Text] [Related]  

  • 12. Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies.
    Fernandes PB; Swanson RN
    Drugs Exp Clin Res; 1988; 14(6):375-8. PubMed ID: 3145851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic resistance of Staphylococcus aureus, selected Enterobacteriaceae, and Pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, and trovafloxacin.
    Gilbert DN; Kohlhepp SJ; Slama KA; Grunkemeier G; Lewis G; Dworkin RJ; Slaughter SE; Leggett JE
    Antimicrob Agents Chemother; 2001 Mar; 45(3):883-92. PubMed ID: 11181375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro studies of synergistic interaction between aztreonam and cefoperazone.
    Borowski J; Zaremba M; FeliƄski J
    Chemioterapia; 1987 Jun; 6(2 Suppl):109-10. PubMed ID: 3151329
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antimicrobial drug therapy and microbial sensitivity tests: general concept of antibiotics].
    Miyazakin S; Yamaguchi K
    Rinsho Byori; 1997 Jul; Suppl 105():162-73. PubMed ID: 9379536
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of resistant bacteria isolated from dogs with otitis externa or urinary tract infections after exposure to enrofloxacin in vitro.
    Brothers AM; Gibbs PS; Wooley RE
    Vet Ther; 2002; 3(4):493-500. PubMed ID: 12584687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bactericidal action of lomefloxacin a new pyridonecarboxylic acid derivative].
    Koikeda S; Okabe H; Shibata H; Hase T; Nakanishi N; Okezaki E; Kato H; Masamune Y
    Jpn J Antibiot; 1989 Jan; 42(1):193-9. PubMed ID: 2468799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New cephalosporin antibiotic: cephapirin].
    Urbinati G
    Clin Ter; 1977 Mar; 80(5):491-9. PubMed ID: 322931
    [No Abstract]   [Full Text] [Related]  

  • 19. [In vitro activity of ciprofloxacin against multiresistant microorganisms isolated from cases of hospital infection].
    Caiaffa Filho HH; Mendes CM
    AMB Rev Assoc Med Bras; 1987; 33(5-6):99-102. PubMed ID: 3129763
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
    Odenholt I; Cars O
    J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.